Teva Bows To $1.4bn US Ingrezza IP With Far Future Settlement
Israeli Firm Must Wait To Broaden TD Portfolio With Distant Settlement Deal
Teva has found a settlement deal with Neurocrine over the TD blockbuster Ingrezza.
Teva has found a settlement deal with Neurocrine over the TD blockbuster Ingrezza.